Cargando…
High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy
AIMS: Patients with renal failure develop cardiovascular alterations which contribute to the higher rate of cardiac death. Blockade of the renin angiotensin system ameliorates the development of such changes. It is unclear, however, to what extent ACE-inhibitors can also reverse existing cardiovascu...
Autores principales: | Tyralla, Karin, Adamczak, Marcin, Benz, Kerstin, Campean, Valentina, Gross, Marie-Luise, Hilgers, Karl F., Ritz, Eberhard, Amann, Kerstin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029304/ https://www.ncbi.nlm.nih.gov/pubmed/21298056 http://dx.doi.org/10.1371/journal.pone.0015287 |
Ejemplares similares
-
Darbepoetin Alpha Reduces Oxidative Stress and Chronic Inflammation in Atherosclerotic Lesions of Apo E Deficient Mice in Experimental Renal Failure
por: Arend, Nicole, et al.
Publicado: (2014) -
Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation
por: Benz, Kerstin, et al.
Publicado: (2018) -
Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats
por: Ritter, Cynthia, et al.
Publicado: (2014) -
Gene Expression Profiling on Global cDNA Arrays Gives Hints
Concerning Potential Signal Transduction Pathways Involved in
Cardiac Fibrosis of Renal Failure
por: Amann, Kerstin, et al.
Publicado: (2003) -
Fibroblast Growth Factor-23—A Potential Uremic Toxin
por: Kuczera, Piotr, et al.
Publicado: (2016)